| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.6 |